Back to HCC home

Text size

Large / Normal

Contact info

Corporate Communications Fax
(860) 224-5779

Both campuses
(860) 224-5695

Other info

Press release details

Hospital vice president named board member, Genomas

New Britain [December 05 2007] - Steven D. Hanks, M.D., MMM, FACP, senior vice president of Medical Affairs and chief medical officer for the Hospital of Central Connecticut, was recently voted a director of the Board of Genomas®, Inc., a Hartford-based biomedical company.

Hanks, who joined the Hospital of Central Connecticut in 2004, is a board-certified internist who also practices as an emergency room physician. He earned his M.D. with distinction in research from the University of Rochester, Rochester, N.Y., and a master’s degree in medical management from Carnegie Mellon’s Heinz School of Public Policy and Management.

He is certified in advanced trauma life support, cardiac life support, and pediatric advanced life support. Hanks, of Farmington, also serves on the boards of the Hartford County Medical Association; New Britain Emergency Medical Services; and is a governor-appointed member of the Connecticut Medical Examining Board.

Genomas is advancing DNA-guided medicine and personalized health. The company, located on the Hartford Hospital campus, develops revolutionary PhyzioType™ medical management systems for DNA-guided diagnosis and prevention of metabolic disorders induced by cardiovascular, diabetes, and psychiatric drugs. PhyzioType systems provide physicians with the capability to select for each patient the safest drug treatment.

In announcing the appointment, Gualberto Ruaño, M.D., Ph.D., Genomas president and CEO, commented, “Dr. Hanks brings the perspective of the experienced practicing physician, healthcare executive, and medical management expert to our board. We are privileged to have him also as a major collaborator in DNA-guided diabetes care. His seasoned perspective lends credibility and strategic value to our company as we advance PhyzioType systems to clinical practice.”

In 2006, The Hospital of Central Connecticut partnered with Genomas, Inc., to develop new DNA diagnostic systems to help select the right drugs and treatments for people with diabetes. This includes management of some related conditions associated with advanced diabetes.

The hospital is an affiliate of the Joslin Diabetes Center in Boston, a world leader in diabetes treatment, research and education. The hospital strives to meet rigorous care standards for people with diabetes, and to help them develop skills to manage their blood sugar, avoid complications and maintain better health throughout their lifetime.

Contact: Kimberly Gensicki, 860-224-5900, ext. 6507














HCC Corporate Communications
(860) 224-5695 • Fax (860) 224-5779